1.705
price up icon9.29%   0.145
 
loading
Curis Inc stock is traded at $1.705, with a volume of 195.95K. It is up +9.29% in the last 24 hours and down -6.32% over the past month. Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
See More
Previous Close:
$1.56
Open:
$1.59
24h Volume:
195.95K
Relative Volume:
1.91
Market Cap:
$21.31M
Revenue:
$10.16M
Net Income/Loss:
$-47.57M
P/E Ratio:
-0.2069
EPS:
-8.24
Net Cash Flow:
$-42.73M
1W Performance:
-6.83%
1M Performance:
-6.32%
6M Performance:
-45.00%
1Y Performance:
-71.20%
1-Day Range:
Value
$1.59
$1.78
1-Week Range:
Value
$1.471
$1.8793
52-Week Range:
Value
$1.02
$6.73

Curis Inc Stock (CRIS) Company Profile

Name
Name
Curis Inc
Name
Phone
617-503-6500
Name
Address
128 SPRING STREET, LEXINGTON, MA
Name
Employee
33
Name
Twitter
@curisinc
Name
Next Earnings Date
2024-10-31
Name
Latest SEC Filings
Name
CRIS's Discussions on Twitter

Compare CRIS with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
CRIS
Curis Inc
1.705 21.62M 10.16M -47.57M -42.73M -8.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
395.12 99.96B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
589.48 60.83B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
454.38 59.89B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
660.00 40.47B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
313.67 37.96B 3.81B -644.79M -669.77M -6.24

Curis Inc Stock (CRIS) Upgrades & Downgrades

Date Action Analyst Rating Change
May-19-25 Resumed H.C. Wainwright Buy
Nov-17-23 Initiated Truist Buy
Apr-04-22 Downgrade Raymond James Outperform → Mkt Perform
Oct-13-21 Initiated Raymond James Outperform
Mar-25-21 Initiated B. Riley Securities Buy
Jul-29-20 Initiated Laidlaw Buy
Jul-17-20 Initiated Cantor Fitzgerald Overweight
Oct-24-17 Initiated Guggenheim Buy
Mar-02-16 Initiated Sun Trust Rbsn Humphrey Buy
Nov-09-15 Reiterated ROTH Capital Buy
Aug-11-15 Initiated FBR Capital Outperform
Jan-22-15 Reiterated Oppenheimer Outperform
Jan-21-15 Reiterated ROTH Capital Buy
May-09-14 Reiterated Oppenheimer Outperform
Oct-02-13 Initiated Robert W. Baird Outperform
Sep-30-13 Initiated Chardan Capital Markets Buy
Nov-14-12 Initiated Stifel Nicolaus Hold
Jan-31-12 Reiterated Brean Murray Buy
Jan-31-12 Reiterated Summer Street Research Buy
Dec-09-11 Initiated Oppenheimer Outperform
Oct-06-11 Initiated Summer Street Research Buy
Sep-22-11 Initiated MLV Capital Buy
Mar-21-11 Reiterated Brean Murray Buy
Feb-26-10 Reiterated Roth Capital Buy
Jan-07-10 Initiated Roth Capital Buy
View All

Curis Inc Stock (CRIS) Latest News

pulisher
Aug 19, 2025

Curis Inc. Stock Approaches Key Moving AverageVolume Spike & AI Optimized Trade Strategies - thegnnews.com

Aug 19, 2025
pulisher
Aug 17, 2025

Institutional Tools Highlight Unusual Flow in Curis Inc.July 2025 Macro Moves & AI Powered Trade Plan Recommendations - 선데이타임즈

Aug 17, 2025
pulisher
Aug 17, 2025

Traders Consider Averaging Down in Curis Inc.2025 Volume Leaders & Advanced Swing Trade Entry Plans - metal.it

Aug 17, 2025
pulisher
Aug 16, 2025

Bollinger Bands Show Potential Breakout in Curis Inc.July 2025 Outlook & Consistent Growth Equity Picks - 선데이타임즈

Aug 16, 2025
pulisher
Aug 16, 2025

How Curis Inc. stock performs during market volatilityJuly 2025 Pullbacks & Weekly Setup with ROI Potential - 선데이타임즈

Aug 16, 2025
pulisher
Aug 15, 2025

Can Curis Inc. continue delivering strong returnsJuly 2025 Breakouts & Technical Confirmation Trade Alerts - mustnews.co.kr

Aug 15, 2025
pulisher
Aug 12, 2025

Market reaction to Curis Inc.’s recent newsAsset Safety Selection Using Quantitative Analysis - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

Exit strategy if you’re trapped in Curis Inc.Next Day Momentum Stock Forecasting Report - Newser

Aug 12, 2025
pulisher
Aug 10, 2025

What makes Curis Inc. stock price move sharplyGiant Leap Stock Alerts - thegnnews.com

Aug 10, 2025
pulisher
Aug 09, 2025

Curis Inc. Receives Buy Rating Due to Promising Clinical Developments and Strong Financial Position. - AInvest

Aug 09, 2025
pulisher
Aug 09, 2025

Curis Files Prospectus Supplement for Stock Offering - MSN

Aug 09, 2025
pulisher
Aug 08, 2025

Curis Inc. Receives Buy Rating Amid Promising Clinical Developments and Strong Financial Position - TipRanks

Aug 08, 2025
pulisher
Aug 08, 2025

Curis targets enrolling 30–40 additional patients for NDA and EMA submissions as emavusertib studies advance - MSN

Aug 08, 2025
pulisher
Aug 08, 2025

Curis, Inc. (NASDAQ:CRIS) Just Reported, And Analysts Assigned A US$16.33 Price Target - simplywall.st

Aug 08, 2025
pulisher
Aug 08, 2025

Curis, Inc. Analysts Trim Price Target After Q2 Report - AInvest

Aug 08, 2025
pulisher
Aug 07, 2025

Curis (CRIS) Reports Q2 Loss, Beats Revenue Estimates - MSN

Aug 07, 2025
pulisher
Aug 07, 2025

Curis, Inc. Reports Q2 2025 Financial and Clinical Progress - The Globe and Mail

Aug 07, 2025
pulisher
Aug 06, 2025

Curis 2025 Q2 Earnings Narrowed Losses Amid Strong Revenue Growth - AInvest

Aug 06, 2025
pulisher
Aug 06, 2025

Curis, Inc. shares rise 1.74% intraday as Swiss president meets business leaders in Washington ahead of tariff talks. - AInvest

Aug 06, 2025
pulisher
Aug 06, 2025

Curis Inc (CRIS) Q2 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges - Yahoo Finance

Aug 06, 2025
pulisher
Aug 06, 2025

Curis Inc (CRIS) Q2 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges By GuruFocus - Investing.com Canada

Aug 06, 2025
pulisher
Aug 06, 2025

Curis, Inc. (NASDAQ:CRIS) Q2 2025 Earnings Call Transcript - Insider Monkey

Aug 06, 2025
pulisher
Aug 06, 2025

Curis Provides Second Quarter 2025 Business Update - BioSpace

Aug 06, 2025
pulisher
Aug 06, 2025

Curis: Q2 Earnings Snapshot - New Haven Register

Aug 06, 2025
pulisher
Aug 05, 2025

Curis Inc. Earnings Call: Progress Amid Challenges - TipRanks

Aug 05, 2025
pulisher
Aug 05, 2025

Curis Inc. Q2 Earnings Call Highlights: Progress Amid Challenges - AInvest

Aug 05, 2025
pulisher
Aug 05, 2025

Curis (CRIS) Q2 Loss Narrows 66% - The Motley Fool

Aug 05, 2025
pulisher
Aug 05, 2025

Curis Inc: Promising Financial Performance and Clinical Advancements Justify Buy Rating - TipRanks

Aug 05, 2025
pulisher
Aug 05, 2025

Earnings call transcript: Curis Inc’s Q2 2025 sees reduced losses, stock rises - Investing.com

Aug 05, 2025
pulisher
Aug 05, 2025

Earnings call transcript: Curis Inc’s Q2 2025 sees reduced losses, stock rises By Investing.com - Investing.com South Africa

Aug 05, 2025
pulisher
Aug 05, 2025

Curis Inc: A High-Conviction Biotech Play with Accelerating Catalysts in Hematology - AInvest

Aug 05, 2025
pulisher
Aug 05, 2025

Curis, Inc. Q2 2025: Unraveling Contradictions in Enrollment Strategy, FDA Dynamics, and PCNSL Data Expectations - AInvest

Aug 05, 2025
pulisher
Aug 05, 2025

Transcript : Curis, Inc., Q2 2025 Earnings Call, Aug 05, 2025 - MarketScreener

Aug 05, 2025
pulisher
Aug 05, 2025

Curis Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 05, 2025
pulisher
Aug 05, 2025

Curis Inc (CRIS) Q2 2025 Earnings: EPS of -$0.68 Beats Estimate, Revenue Hits $2.7 Million - GuruFocus

Aug 05, 2025
pulisher
Aug 05, 2025

Biotech firm Curis Q2 revenue rises to $2.7 mln - MarketScreener

Aug 05, 2025
pulisher
Aug 04, 2025

Curis Inc (CRIS) Q2 2025 Earnings Report Preview: What To Expect - Yahoo Finance

Aug 04, 2025
pulisher
Aug 04, 2025

How strong is Curis Inc. company’s balance sheetTrack top-performing stocks effortlessly - Jammu Links News

Aug 04, 2025
pulisher
Aug 04, 2025

What are the technical indicators suggesting about Curis Inc.Exceptional gains - Jammu Links News

Aug 04, 2025
pulisher
Aug 04, 2025

Curis Inc Q2 2025 Earnings Report Preview: Revenue Expected to Reach $2.64 Million, Earnings at -$1.36 per Share - AInvest

Aug 04, 2025
pulisher
Aug 03, 2025

What catalysts could drive Curis Inc. stock higher in 2025Achieve breakthrough investment performance - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How does Curis Inc. compare to its industry peersGet real-time updates on market trends - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What drives Curis Inc. stock priceUnmatched market gains - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are Curis Inc. company’s key revenue driversInvest smarter with daily trading signals - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are analysts’ price targets for Curis Inc. in the next 12 monthsTurn volatility into profit opportunities - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What is Curis Inc. company’s growth strategyBreakthrough financial growth - Jammu Links News

Aug 03, 2025

Curis Inc Stock (CRIS) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$24.65
price up icon 0.94%
$85.04
price down icon 1.72%
$26.20
price up icon 0.73%
$110.88
price up icon 0.10%
$131.88
price down icon 0.54%
biotechnology ONC
$313.67
price down icon 0.10%
Cap:     |  Volume (24h):